Abstract
INTRODUCTION
The association of blood-based biomarkers of neuropathology with cognition, dementia, and mortality and how these association potentially differ by race/ethnicity, has not been examined in large, diverse, nationally-representative samples of adults.
METHODS
The sample included Health and Retirement Study (HRS) respondents over age 50 with blood-based neuropathology biomarker, demographic, and cognitive data (n=4,214). A β -40, A β -42, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) were measured in plasma (Quanterix Neurology 4-Plex E kit), and phosphorylated tau (pTau-181) was measured in serum (Quanterix Advantage V2.0 kit). Cognitive tests included immediate and delayed word recall, serial 7s, and backward counting (total score 0-27). Dementia classification relied on a diagnostic algorithm previously validated in the HRS.
RESULTS
When each biomarker was analyzed individually, higher A β -42/A β -40 ratio was associated with better cognitive function among non-Hispanic (NH) whites. Higher NfL was associated with worse cognitive function in the total sample and in each race/ethnic group (NH white, NH black, and Hispanic). Higher pTau-181 was associated with worse cognitive function in the total and NH white sample. Higher GFAP was related to worse cognitive function in the total sample only. In a model that included all four biomarkers, NfL remained significantly related to cognitive performance in the total sample and in each race/ethnic group, and irrespective of APOE status. NfL was predictive of 6-year incident dementia in our sample (OR=1.33). All four markers significantly predicted 6-year mortality.
DISCUSSION
In a large nationally-representative sample of US adults, we found that NfL was the most consistent predictor of cross-sectional and incident dementia 6 years post blood collection. NfL was also the most consistent predictor across race/ethnic groups examined in our study.
Highlights
There are currently limited data on blood-based biomarkers of neuropathology as predictors of cognitive performance and incident dementia in diverse, population-based cohort studies.
We used data from the Health and Retirement Study (n-=4,214) to examine the association between blood-based biomarkers of neuropathology and cognitive function, as well as their association with incident dementia and mortality 4 years after measurement.
Mean levels of A β -42/A β -40 were similar across race/ethnic groups and age groups in this US population-representative sample where selection effects have been minimized. Average NfL was higher among non-Hispanic blacks and Hispanics; GFAP was higher among non-Hispanic blacks as compared to non-Hispanic whites.
In a model that included all four biomarkers, NfL remained significantly related to cognitive performance in the total sample and in each race/ethnic group.
NfL was associated with incident dementia 6 years after measurement in the total sample. A β -42/A β -40 ratio was predictive of 6-year incident dementia among those with at least one APOE e4 allele.
Full Text Availability
The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.
